HPS-088 - Use of proton pump inhibitors during the first year of life and late complications

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-088
• By: HAMZA, Kamelia (clinical hospital pharmacy, Israel)
• Co-author(s): Mrs Kamelia Hamza (clinical hospital pharmacy, kawkab abu el hija, Israel)
  
• Abstract:

  Background:
  proton pump inhibitors (PPIs) are the most prescribed drug classes for pediatric gastroesophageal reflux disease (GERD). Several studies reported on the dramatic increase in the use of PPIs among infants, despite the limit efficacy in relieving GER symptoms.
  Inappropriate PPI's use is a matter of great concern, especially after the..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login